←Back to list

Qogita

Developer of a wholesale business-to-business (B2B) platform designed to increase market efficiency and supply chain mar
Developer of a wholesale business-to-business (B2B) platform designed to increase market efficiency and supply chain margins.
Media and Information Services (B2B) 📍 Amsterdam, Netherlands Founded 2019
Current Valuation
$673.28M
as of 2022-Q1
PRIVATE

QL Price

$673.28M
0% vs last round
QuantLogix's current estimate for Qogita, published 2026-09-27 — in line with the last disclosed round of $673.28M (2022-Q1).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $673.28M 2022-Q1 weight 0.04
How this price has held up
No round has priced for Qogita since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Qogita →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Qogita, 2026-09-27 (e517869adbc30d62). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Qogita going public?
No. Qogita is private and has not filed to go public. There is no S-1 on file.
What is Qogita's valuation in 2026?
Qogita is valued at $673.28M as of 2022-Q1, set by its Series B ($82.51M, Mar 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Qogita filed an S-1?
No public S-1 is on file for Qogita.
How much has Qogita raised?
Qogita has raised $113.53M in total, most recently a Series B of $82.51M in Mar 2022.
Is Qogita publicly traded — can you buy Qogita stock?
No. Qogita is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Qogita on its Pre-IPO Access Desk.
How to actually get exposure to Qogita →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
2019
HQ
Amsterdam, Netherlands
Employees
178
Total Raised
$113.53M
Last Round
Series B — $82.51M (Mar 2022)
IPO Status
private

Fundraising Status

Series B · $82.51M · 4y 6mo ago
privateTotal raised $113.53M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series B$82.51MMar 2022—$673.28M

Talent Signal

Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
15
via careers page
Product-build share
40%
engineering, research, product, design
Trajectory
steady
balanced build + GTM — 40% builders vs 60% go-to-market/G&A — scaling both sides.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month15Aug '2615Sep '26
Open roles by function
Open roles by functionClinical & Science6Sales & GTM3Marketing3Support2Legal & Policy1
■ product-building   ■ go-to-market / G&A
Medical TestsMedical EquipmentPharmacy Solutions[Medical Tests](https://www.qogita.com/categories/health-beauty/health/medical-t[All categories](https://www.qogita.com/categories/health-beauty/health/medical/[Pharmacy Solutions](https://www.qogita.com/pharmacy/)
Counted from Qogita's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
B2BE-CommerceWholesale
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.